Cargando…
Botulinum neurotoxin (BoNT) treatment in functional movement disorders: long-term follow-up
Autores principales: | Dreissen, Yasmine EM, Lambert, Franka, Dijk, Joke M, Koelman, Johannes HTM, Tijssen, Marina AJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509513/ https://www.ncbi.nlm.nih.gov/pubmed/32661081 http://dx.doi.org/10.1136/jnnp-2020-323684 |
Ejemplares similares
-
Long-term follow-up of acute functional stroke mimic in comparison to mild acute ischaemic stroke
por: Lambert, Franka, et al.
Publicado: (2022) -
The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study
por: Varley, James A, et al.
Publicado: (2019) -
Prognostic relationship of neurofilaments, CHIT1, YKL-40 and MCP-1 in amyotrophic lateral sclerosis
por: Masrori, Pegah, et al.
Publicado: (2022) -
Navigating the Complexities Involving the Identification of Botulinum Neurotoxins (BoNTs) and the Taxonomy of BoNT-Producing Clostridia
por: Smith, Theresa J., et al.
Publicado: (2023) -
CD8 T cell deficiency impairs control of Epstein–Barr virus and worsens with age in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2011)